BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

BIO-FD&C Statistics

Total Valuation

BIO-FD&C has a market cap or net worth of KRW 164.78 billion. The enterprise value is 116.96 billion.

Market Cap	164.78B
Enterprise Value	116.96B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BIO-FD&C has 8.70 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	8.70M
Shares Outstanding	8.70M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	31.43%
Owned by Institutions (%)	0.22%
Float	5.15M

Valuation Ratios

The trailing PE ratio is 26.00.

PE Ratio	26.00
Forward PE	n/a
PS Ratio	9.50
PB Ratio	2.48
P/TBV Ratio	2.49
P/FCF Ratio	25.24
P/OCF Ratio	22.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.25, with an EV/FCF ratio of 17.91.

EV / Earnings	18.83
EV / Sales	6.74
EV / EBITDA	16.25
EV / EBIT	19.68
EV / FCF	17.91

Financial Position

The company has a current ratio of 19.34, with a Debt / Equity ratio of 0.00.

Current Ratio	19.34
Quick Ratio	18.27
Debt / Equity	0.00
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	94.12

Financial Efficiency

Return on equity (ROE) is 9.79% and return on invested capital (ROIC) is 5.79%.

Return on Equity (ROE)	9.79%
Return on Assets (ROA)	5.55%
Return on Invested Capital (ROIC)	5.79%
Return on Capital Employed (ROCE)	8.90%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	2.46

Taxes

In the past 12 months, BIO-FD&C has paid 931.24 million in taxes.

Income Tax	931.24M
Effective Tax Rate	13.04%

Stock Price Statistics

The stock price has increased by +28.13% in the last 52 weeks. The beta is 0.77, so BIO-FD&C's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+28.13%
50-Day Moving Average	19,567.00
200-Day Moving Average	15,659.10
Relative Strength Index (RSI)	52.27
Average Volume (20 Days)	37,993

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-FD&C had revenue of KRW 17.34 billion and earned 6.21 billion in profits. Earnings per share was 728.71.

Revenue	17.34B
Gross Profit	12.33B
Operating Income	5.94B
Pretax Income	7.14B
Net Income	6.21B
EBITDA	7.20B
EBIT	5.94B
Earnings Per Share (EPS)	728.71

Balance Sheet

The company has 48.12 billion in cash and 293.37 million in debt, giving a net cash position of 47.82 billion or 5,499.79 per share.

Cash & Cash Equivalents	48.12B
Total Debt	293.37M
Net Cash	47.82B
Net Cash Per Share	5,499.79
Equity (Book Value)	66.52B
Book Value Per Share	7,797.60
Working Capital	50.23B

Cash Flow

In the last 12 months, operating cash flow was 7.43 billion and capital expenditures -896.75 million, giving a free cash flow of 6.53 billion.

Operating Cash Flow	7.43B
Capital Expenditures	-896.75M
Free Cash Flow	6.53B
FCF Per Share	750.91

Margins

Gross margin is 71.09%, with operating and profit margins of 34.27% and 35.82%.

Gross Margin	71.09%
Operating Margin	34.27%
Pretax Margin	41.19%
Profit Margin	35.82%
EBITDA Margin	41.50%
EBIT Margin	34.27%
FCF Margin	37.65%

Dividends & Yields

BIO-FD&C does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	n/a
Earnings Yield	3.77%
FCF Yield	3.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-FD&C has an Altman Z-Score of 28.22 and a Piotroski F-Score of 6.

Altman Z-Score	28.22
Piotroski F-Score	6